Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Securian Asset Management Inc.

Securian Asset Management Inc. lowered its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 2.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,905 shares of the biotechnology company’s stock after selling 100 shares during the quarter. Securian Asset Management Inc.’s holdings in Axon Enterprise were worth $2,321,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. SHEPHERD WEALTH MANAGEMENT Ltd LIABILITY Co acquired a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $1,050,000. Farther Finance Advisors LLC increased its stake in shares of Axon Enterprise by 66.4% during the fourth quarter. Farther Finance Advisors LLC now owns 1,456 shares of the biotechnology company’s stock valued at $865,000 after acquiring an additional 581 shares during the period. EverSource Wealth Advisors LLC increased its stake in shares of Axon Enterprise by 12.3% during the fourth quarter. EverSource Wealth Advisors LLC now owns 311 shares of the biotechnology company’s stock valued at $185,000 after acquiring an additional 34 shares during the period. Sequoia Financial Advisors LLC increased its stake in shares of Axon Enterprise by 67.8% during the fourth quarter. Sequoia Financial Advisors LLC now owns 2,898 shares of the biotechnology company’s stock valued at $1,722,000 after acquiring an additional 1,171 shares during the period. Finally, Wealthfront Advisers LLC increased its stake in shares of Axon Enterprise by 3,876.0% during the fourth quarter. Wealthfront Advisers LLC now owns 25,049 shares of the biotechnology company’s stock valued at $14,887,000 after acquiring an additional 24,419 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Buying and Selling

In related news, President Joshua Isner sold 1,291 shares of the firm’s stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total value of $829,377.13. Following the completion of the transaction, the president now owns 181,892 shares of the company’s stock, valued at approximately $116,852,877.56. This trade represents a 0.70 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the completion of the sale, the director now owns 24,259 shares of the company’s stock, valued at approximately $15,518,239.71. The trade was a 3.96 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 5,146 shares of company stock valued at $3,262,847. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Trading Down 4.2 %

Axon Enterprise stock opened at $534.56 on Friday. The company has a 50 day moving average price of $595.56 and a 200 day moving average price of $532.90. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm has a market capitalization of $40.96 billion, a price-to-earnings ratio of 138.13, a P/E/G ratio of 5.17 and a beta of 1.12.

Analyst Ratings Changes

A number of research firms recently commented on AXON. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday. Needham & Company LLC reiterated a “buy” rating and set a $600.00 price objective on shares of Axon Enterprise in a research note on Wednesday, February 26th. Robert W. Baird raised their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Finally, The Goldman Sachs Group raised their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $604.67.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.